Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Hepatitis B virus X protein inhibits extracellular IFN-α-mediated signal transduction by downregulation of type I IFN receptor.

Cho IR, Oh M, Koh SS, Malilas W, Srisuttee R, Jhun BH, Pellegrini S, Fuchs SY, Chung YH.

Int J Mol Med. 2012 Apr;29(4):581-6. doi: 10.3892/ijmm.2012.879. Epub 2012 Jan 3.

2.

Expression of HBX, an oncoprotein of hepatitis B virus, blocks reoviral oncolysis of hepatocellular carcinoma cells.

Park EH, Koh SS, Srisuttee R, Cho IR, Min HJ, Jhun BH, Lee YS, Jang KL, Kim CH, Johnston RN, Chung YH.

Cancer Gene Ther. 2009 May;16(5):453-61. doi: 10.1038/cgt.2008.95. Epub 2008 Dec 19.

PMID:
19096445
4.
5.
6.

Palmitoylation of interferon-alpha (IFN-alpha) receptor subunit IFNAR1 is required for the activation of Stat1 and Stat2 by IFN-alpha.

Claudinon J, Gonnord P, Beslard E, Marchetti M, Mitchell K, Boularan C, Johannes L, Eid P, Lamaze C.

J Biol Chem. 2009 Sep 4;284(36):24328-40. doi: 10.1074/jbc.M109.021915. Epub 2009 Jun 26.

7.

Interferon-alpha restrains growth and invasive potential of hepatocellular carcinoma induced by hepatitis B virus X protein.

Yang JQ, Pan GD, Chu GP, Liu Z, Liu Q, Xiao Y, Yuan L.

World J Gastroenterol. 2008 Sep 28;14(36):5564-9; discussion 5568.

8.

Suppressor of cytokine signaling (SOCS) 1 inhibits type I interferon (IFN) signaling via the interferon alpha receptor (IFNAR1)-associated tyrosine kinase Tyk2.

Piganis RA, De Weerd NA, Gould JA, Schindler CW, Mansell A, Nicholson SE, Hertzog PJ.

J Biol Chem. 2011 Sep 30;286(39):33811-8. doi: 10.1074/jbc.M111.270207. Epub 2011 Jul 13.

9.

The hepatitis B virus X protein disrupts innate immunity by downregulating mitochondrial antiviral signaling protein.

Wei C, Ni C, Song T, Liu Y, Yang X, Zheng Z, Jia Y, Yuan Y, Guan K, Xu Y, Cheng X, Zhang Y, Yang X, Wang Y, Wen C, Wu Q, Shi W, Zhong H.

J Immunol. 2010 Jul 15;185(2):1158-68. doi: 10.4049/jimmunol.0903874. Epub 2010 Jun 16.

10.

Human metapneumovirus inhibits IFN-alpha signaling through inhibition of STAT1 phosphorylation.

Dinwiddie DL, Harrod KS.

Am J Respir Cell Mol Biol. 2008 Jun;38(6):661-70. doi: 10.1165/rcmb.2007-0285OC. Epub 2008 Jan 24.

PMID:
18218993
11.

Localization of a receptor nonapeptide with a possible role in the binding of the type I interferons.

Eid P, Langer JA, Bailly G, Lejealle R, Guymarho J, Tovey MG.

Eur Cytokine Netw. 2000 Dec;11(4):560-73.

PMID:
11125298
12.

Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma.

Kim KH, Shin HJ, Kim K, Choi HM, Rhee SH, Moon HB, Kim HH, Yang US, Yu DY, Cheong J.

Gastroenterology. 2007 May;132(5):1955-67. Epub 2007 Mar 24.

PMID:
17484888
13.

Dengue virus type 2 antagonizes IFN-alpha but not IFN-gamma antiviral effect via down-regulating Tyk2-STAT signaling in the human dendritic cell.

Ho LJ, Hung LF, Weng CY, Wu WL, Chou P, Lin YL, Chang DM, Tai TY, Lai JH.

J Immunol. 2005 Jun 15;174(12):8163-72.

14.

Role of ISGF3 in modulating the anti-hepatitis B virus activity of interferon-alpha in vitro.

Zhang Q, Wang Y, Wei L, Jiang D, Wang JH, Rao HY, Zhu L, Chen H, Fei R, Cong X.

J Gastroenterol Hepatol. 2008 Nov;23(11):1747-61. Epub 2007 Jun 7.

PMID:
17559358
15.

Mechanism of HCV's resistance to IFN-α in cell culture involves expression of functional IFN-α receptor 1.

Datta S, Hazari S, Chandra PK, Samara M, Poat B, Gunduz F, Wimley WC, Hauser H, Koster M, Lamaze C, Balart LA, Garry RF, Dash S.

Virol J. 2011 Jul 14;8:351. doi: 10.1186/1743-422X-8-351.

17.

Down-modulation of type 1 interferon responses by receptor cross-competition for a shared Jak kinase.

Dondi E, Pattyn E, Lutfalla G, Van Ostade X, Uzé G, Pellegrini S, Tavernier J.

J Biol Chem. 2001 Dec 14;276(50):47004-12. Epub 2001 Oct 15.

18.

Suppression of interferon-α signaling by hepatitis E virus.

Dong C, Zafrullah M, Mixson-Hayden T, Dai X, Liang J, Meng J, Kamili S.

Hepatology. 2012 May;55(5):1324-32. doi: 10.1002/hep.25530. Epub 2012 Apr 4.

PMID:
22183878
19.

Up-regulation of Foxo4 mediated by hepatitis B virus X protein confers resistance to oxidative stress-induced cell death.

Srisuttee R, Koh SS, Park EH, Cho IR, Min HJ, Jhun BH, Yu DY, Park S, Park DY, Lee MO, Castrillon DH, Johnston RN, Chung YH.

Int J Mol Med. 2011 Aug;28(2):255-60. doi: 10.3892/ijmm.2011.699. Epub 2011 May 11.

PMID:
21567078
20.

Pancreatic adenocarcinoma upregulated factor (PAUF) confers resistance to pancreatic cancer cells against oncolytic parvovirus H-1 infection through IFNA receptor-mediated signaling.

Kaowinn S, Cho IR, Moon J, Jun SW, Kim CS, Kang HY, Kim M, Koh SS, Chung YH.

Biochem Biophys Res Commun. 2015 Apr 3;459(2):313-8. doi: 10.1016/j.bbrc.2015.02.107. Epub 2015 Feb 26.

PMID:
25727013
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk